MMP3 as a new target of Danshensu/tetramethylpyrazine derivative for attenuating cardiac fibrosis post-myocardial infarction

Tetramethylpyrazine MMP3 Cardiac Fibrosis Myocardial fibrosis Derivative (finance)
DOI: 10.1016/j.lfs.2025.123570 Publication Date: 2025-03-19T00:15:46Z